Literature DB >> 23116446

Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis.

A Guentsch1, C Hirsch, W Pfister, B Vincents, M Abrahamson, A Sroka, J Potempa, S Eick.   

Abstract

BACKGROUND AND OBJECTIVES: Immunoglobulin (Ig) G1 plays an important role in the adaptive immune response. Kgp, a lysine-specific cysteine protease from Porphyromonas gingivalis, specifically hydrolyses IgG1 heavy chains. The purpose of this study was to examine whether cleavage of IgG1 occurs in gingival crevicular fluid (GCF) in vivo, and whether there is any association with the presence of Porphyromonas gingivalis and other periodontopathogens.
MATERIAL AND METHODS: GCF was obtained from nine patients with aggressive periodontitis, nine with chronic periodontitis and five periodontally healthy individuals. The bacterial loads of Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Treponema denticola, Prevotella intermedia and Tannerella forsythia were analysed by real-time polymerase chain reaction, and the presence and cleavage of IgG1 and IgG2 were determined using Western blotting. Kgp levels were measured by ELISA.
RESULTS: Cleaved IgG1 was identified in the GCF from 67% of patients with aggressive periodontitis and in 44% of patients with chronic periodontitis. By contrast, no cleaved IgG1 was detectable in healthy controls. No degradation of IgG2 was detected in any of the samples, regardless of health status. Porphyromonas gingivalis was found in high numbers in all samples in which cleavage of IgG1 was detected (P < 0.001 compared with samples with no IgG cleavage). Furthermore, high numbers of Tannerella forsythia and Prevotella intermedia were also present in these samples. The level of Kgp in the GCF correlated with the load of Porphyromonas gingivalis (r = 0.425, P < 0.01). The presence of Kgp (range 0.07-10.98 ng/mL) was associated with proteolytic fragments of IgG1 (P < 0.001). However, cleaved IgG1 was also detected in samples with no detectable Kgp.
CONCLUSION: In patients with periodontitis, cleavage of IgG1 occurs in vivo and may suppress antibody-dependent antibacterial activity in subgingival biofilms especially those colonized by Porphyromonas gingivalis.
© 2012 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116446      PMCID: PMC3566341          DOI: 10.1111/jre.12027

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  55 in total

1.  Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment.

Authors:  Sigrun Eick; Anna Straube; Arndt Guentsch; Wolfgang Pfister; Holger Jentsch
Journal:  Diagn Microbiol Infect Dis       Date:  2011-01       Impact factor: 2.803

2.  Adsorption of components of the plasma kinin-forming system on the surface of Porphyromonas gingivalis involves gingipains as the major docking platforms.

Authors:  Maria Rapala-Kozik; Grazyna Bras; Barbara Chruscicka; Justyna Karkowska-Kuleta; Aneta Sroka; Heiko Herwald; Ky-Anh Nguyen; Sigrun Eick; Jan Potempa; Andrzej Kozik
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  Comparison of gingival crevicular fluid sampling methods in patients with severe chronic periodontitis.

Authors:  Arndt Guentsch; Martin Kramesberger; Aneta Sroka; Wolfgang Pfister; Jan Potempa; Sigrun Eick
Journal:  J Periodontol       Date:  2011-01-14       Impact factor: 6.993

Review 4.  The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibition.

Authors:  Tang Yongqing; Jan Potempa; Robert N Pike; Lakshmi C Wijeyewickrema
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis.

Authors:  Bjarne Vincents; Arndt Guentsch; Dominika Kostolowska; Ulrich von Pawel-Rammingen; Sigrun Eick; Jan Potempa; Magnus Abrahamson
Journal:  FASEB J       Date:  2011-07-18       Impact factor: 5.191

6.  Periodontal pathogen carriage, rather than periodontitis, determines the serum antibody levels.

Authors:  Pirkko J Pussinen; Eija Könönen; Susanna Paju; Kati Hyvärinen; Ulvi Kahraman Gursoy; Sisko Huumonen; Matti Knuuttila; Anna L Suominen
Journal:  J Clin Periodontol       Date:  2011-03-01       Impact factor: 8.728

7.  Periodontal pathogens affect the level of protease inhibitors in gingival crevicular fluid.

Authors:  O Laugisch; M Schacht; A Guentsch; T Kantyka; A Sroka; H R Stennicke; W Pfister; A Sculean; J Potempa; S Eick
Journal:  Mol Oral Microbiol       Date:  2011-12-07       Impact factor: 3.563

Review 8.  Corruption of innate immunity by bacterial proteases.

Authors:  Jan Potempa; Robert N Pike
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

9.  Elafin is specifically inactivated by RgpB from Porphyromonas gingivalis by distinct proteolytic cleavage.

Authors:  Tomasz Kantyka; Ties Latendorf; Oliver Wiedow; Joachim Bartels; Regine Gläser; Grzegorz Dubin; Jens-Michael Schröder; Jan Potempa; Ulf Meyer-Hoffert
Journal:  Biol Chem       Date:  2009-12       Impact factor: 3.915

Review 10.  The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies.

Authors:  Randall J Brezski; David M Knight; Robert E Jordan
Journal:  ScientificWorldJournal       Date:  2011-05-26
View more
  11 in total

Review 1.  The case for periodontitis in the pathogenesis of rheumatoid arthritis.

Authors:  Jan Potempa; Piotr Mydel; Joanna Koziel
Journal:  Nat Rev Rheumatol       Date:  2017-08-24       Impact factor: 20.543

2.  In vivo expression of proteases and protease inhibitor, a serpin, by periodontal pathogens at teeth and implants.

Authors:  M Eckert; D Mizgalska; A Sculean; J Potempa; A Stavropoulos; S Eick
Journal:  Mol Oral Microbiol       Date:  2018-04-17       Impact factor: 3.563

3.  Engineered protease-resistant antibodies with selectable cell-killing functions.

Authors:  Michelle Kinder; Allison R Greenplate; Katharine D Grugan; Keri L Soring; Katharine A Heeringa; Stephen G McCarthy; Gregory Bannish; Meredith Perpetua; Frank Lynch; Robert E Jordan; William R Strohl; Randall J Brezski
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

4.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

Review 5.  Oral fluid-based biomarkers in periodontal disease - part 2. Gingival crevicular fluid.

Authors:  Raed AlRowis; Hani S AlMoharib; Abdulrahman AlMubarak; Jagankumar Bhaskardoss; R S Preethanath; Sukumaran Anil
Journal:  J Int Oral Health       Date:  2014-09

Review 6.  Protease inhibition as new therapeutic strategy for GI diseases.

Authors:  Nathalie Vergnolle
Journal:  Gut       Date:  2016-04-12       Impact factor: 23.059

Review 7.  Manipulation of Neutrophils by Porphyromonas gingivalis in the Development of Periodontitis.

Authors:  Maja Sochalska; Jan Potempa
Journal:  Front Cell Infect Microbiol       Date:  2017-05-23       Impact factor: 5.293

Review 8.  Purinergic signaling during Porphyromonas gingivalis infection.

Authors:  Cássio Luiz Coutinho Almeida-da-Silva; Ana Carolina Morandini; Henning Ulrich; David M Ojcius; Robson Coutinho-Silva
Journal:  Biomed J       Date:  2016-09-24       Impact factor: 4.910

9.  Intraspecies Variability Affects Heterotypic Biofilms of Porphyromonas gingivalis and Prevotella intermedia: Evidences of Strain-Dependence Biofilm Modulation by Physical Contact and by Released Soluble Factors.

Authors:  Graziela Murta Barbosa; Andrea Vieira Colombo; Paulo Henrique Rodrigues; Maria Regina Lorenzetti Simionato
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  Human Neutrophil Elastase Proteolytic Activity in Ulcerative Colitis Favors the Loss of Function of Therapeutic Monoclonal Antibodies.

Authors:  Renata Curciarello; Toni Sobande; Samantha Jones; Paolo Giuffrida; Antonio Di Sabatino; Guillermo H Docena; Thomas T MacDonald; Klaartje Kok
Journal:  J Inflamm Res       Date:  2020-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.